Development of approach to remote personal ECG monitoring/ECG express
The project aims at the development of an approach to remote personal ECG monitoring (abnormal ST segment and cardiac arrhythmias) in patients with coronary artery disease (CAD) with high risk of the development of acute myocardial infarction and sudden cardiac death.
The project will solve the problem of prompt ECG registration even in the extreme conditions without help of a specialist and with a capability of instant ECG transfer to specialized centers for quick diagnostics of abnormal blood supply to the myocardium,
The first trial amount of devices with implemented solutions of the module for registration of thoracic leads and
Key advantages of the device are as follows:
- Prompt diagnosing in critical situations
- Feasibility of individual control
- Simplicity and high speed of the use
- Affordable price
new-generation coronary stent
The product will allow solving the following problems of currently available stents:
- restenosis of coronary arteries caused by the endothelial growth and atherosclerotic plaque in the area of placed coronary stents.
- reducing the risk of myocardial infarction onset and sudden cardiac death
Currently, the project is at the R&D stage. In 2015 and in the beginning of 2016, we had completed the work stages, which received finding from the Foundation for Assistance to Small Innovative Enterprises in Science and Technology and, as a result, initiated creation of
The next stage of work was «The study of the effects of biodegradable material containing nanoparticles, used for vascular stent coating, on the morphofunctional state of biological tissues».
In 2018, under support of Skolkovo Foundation, we performed works on «Research tests to characterize local effects of the object — medical product, namely — samples of coronary stent with biodegradable coating with different concentrations of chemically modified nanomaterial». The results of the study allowed to elucidate the optimal concentration of nanomaterial present in the composition of the biodegradable coating (3%).
The next step of the works consists in the assessment of morphofunctional changes in the surrounding tissues of the experimental animals after the implantation of the samples of the vascular stent with 3%-content of carbon nanocomposites in the